Bellevue Asset Management »

Centessa Pharmaceuticals shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7k 70 24.24
2025-03-31 $1.0k 70 14.39

More positions owned by Bellevue Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange- Traded Fst Low Oppt Etf (LMBS)
Costco Wholesale Corporation (COST)
Amazon (AMZN)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Fds Inf Tech Etf (VGT)
Tcw Etf Trust Flexible Income (FLXR)
Jp Morgan Exchange Traded F Short Dura Core (JSCP)
First Tr Exchange-traded First Tr Enh New (FTSM)
Starbucks Corporation (SBUX)
Blackrock Etf Trust Ishares Technolo (TEK)

View all positions for Bellevue Asset Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
First Light Asset Management
Siren
TCG Crossover Management
Perceptive Advisors
Commodore Capital
Franklin Resources
Rtw Investments
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals